The FDA Approved the First-Ever Drug to Treat Children with Peanut Allergies
The first-ever drug to treat peanut allergies was approved in the United States. This drug, under the designation AR101 and with the commercial name Palforzia, is available in the form of a powder that is sprinkled on food.
The course of treatment lasts for six months – during this time, patients take an increasing amount of the drug, which contains peanut protein. As a result, the body gradually develops a certain tolerance for peanuts.
This drug does not relieve patients of allergies, and its manufacturers warn that there remains a risk of deadly anaphylactic shock.
In addition, even after six months of treatment, patients must continue to take the drug daily to avoid an allergic reaction if they accidentally eat peanuts. And, of course, they shouldn’t eat peanuts.
Nuts are the most common food allergen in the United States, and in Western countries in recent decades, more and more people suffer from food allergies.
The drug Palforzia is recognized as suitable for the treatment of patients aged 4 to 17 years.
Its cost is extremely high – the manufacturing company reported that a monthly course of the drug will cost patients $ 890.